Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2026 08:00 ET | Source: Komprise

New Komprise Flash Stretch Enables Enterprises to Stretch Existing Hot Storage Capacity

CAMPBELL, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Komprise, the leader in analytics-driven unstructured data management, today announces Komprise Flash Stretch, an enterprise IT assessment that...
March 25, 2026 09:00 ET | Source: Ledyard Financial Group

Jennifer Williams Joins Board of Directors of Ledyard Financial Group, Inc.

HANOVER, N.H., March 25, 2026 (GLOBE NEWSWIRE) -- Ledyard Financial Group, Inc. (OTCQX®: LFGP) (the “Company”), the holding company for Ledyard National Bank (the “Bank”), today announced that...
March 25, 2026 07:00 ET | Source: Westhaven Gold Corp.

Westhaven Engages San Diego Torrey Hills Capital for Investor Relations

VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (OTCQB: WTHVF) (“Westhaven” or the “Company”) is pleased to announce that it has entered into an...
March 23, 2026 09:00 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of NuScale Power Corporation Investors

LOS ANGELES, March 23, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises NuScale Power Corporation, (“NuScale” or the "Company") (NYSE: SMR) investors off a class action on behalf of investors...
March 23, 2026 08:30 ET | Source: Robbins Geller Rudman & Dowd LLP

SMR INVESTOR ALERT: NuScale Power Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action filed by RGRD Law

The case alleges that NuScale failed to disclose that it entrusted its NPM commercialization to an entity that lacked significant prior experience.
March 19, 2026 08:45 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder

Vancouver, Canada, March 19, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development...
March 18, 2026 18:10 ET | Source: Ever Joint

Ever Joint Claims Evaluated: What the Science Says About EverJoint Joint Support Ingredients

Company-issued report examining Ever Joint ingredient research, dosing transparency, oxidative stress claims, and consumer verification steps.
March 18, 2026 12:00 ET | Source: Riverside Insights

Riverside Insights Acquires Move This World to Advance a Connected System for Student Behavioral and Mental Health

ITASCA, Ill., March 18, 2026 (GLOBE NEWSWIRE) -- Riverside Insights, a leading provider of trusted, research-backed assessments, today announced the acquisition of Move This World, a proactive...
March 18, 2026 09:00 ET | Source: KALA BIO, Inc.

Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate

AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio’s purpose-built agentic AI platform for the biotechnology industry TORONTO...
March 18, 2026 06:00 ET | Source: Greenwich LifeSciences, Inc.

Greenwich LifeSciences Provides Update on Upcoming AACR Meeting

STAFFORD, Texas, March 18, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...